SureNano Announces Funding, Debt Settlement and AGSM Results

Rhea-AI Summary

SureNano Science (OTCQB:SURNF) has announced a recapitalization plan consisting of two key components: a $85,000 debt settlement with insider Charles Malette and a private placement to raise up to $215,000. Both transactions will issue shares at $0.10 per share, totaling up to 3,000,000 shares.

The company also reported results from its August 8, 2025 annual general and special meeting, where 70.29% of shareholders participated. All proposed directors were unanimously elected, Buckley Dodds CPA was appointed as auditor, and the long-term incentive plan was approved. Upon completion of the debt settlement, director Charles Malette will own 34.8% of common shares.

Positive

• Successful debt settlement of $85,000 improves balance sheet
• Additional funding of up to $215,000 through private placement
• Strong shareholder participation of 70.29% at AGSM
• Unanimous approval of all proposed corporate actions

Negative

• Significant share dilution with 3,000,000 new shares being issued
• Increased insider control with director owning 34.8% post-transaction
• Funds primarily used for operating expenses rather than growth initiatives

Vancouver, British Columbia--(Newsfile Corp. - August 22, 2025) - SURENANO SCIENCE LTD. (CSE: SURE) (OTCQB: SURNF) (the "Company" or "SureNano") announces its intention to complete a recapitalization consisting of a debt settlement with an insider for $85,000 ("Debt Settlement") and a private placement for proceeds of up to $215,000 (the "Private Placement"). Up to 3,000,000 Private Placement and Debt Settlement shares in total be issued at a price of $0.10 per share subject to CSE approval.

The Company intends to use the cash proceeds for operating expenses, including legal and audit fees and general working capital. All securities issued in the private placement will be subject to a four month and a day hold period.

The Company also announces that it held its annual general and special meeting (the "AGSM") held on August 8, 2025. A total of 10 shareholders voted, in person or by proxy, representing a total of 15,083,100 common shares and 70.29% of the issued and outstanding shares of the Company.

All of the voting shareholders unanimously elected each of the four directors standing for election. The voting shareholders unanimously appointed Buckley Dodds CPA as the auditors for the Company and approved the omnibus long-term incentive plan of the Company.

The Debt Settlement is with a related party, director Charles Malette, but is exempt from valuation and minority shareholder approval requirements under NI 61-101 on account of being an amount less than 25% of capitalization. On completion of the Debt Settlement Mr. Malette will own 8,521,600 shares of the Company (34.8% of common shares then issued). The private Placement is to arms-length investors.

About SureNano Science Ltd.:

The business of SureNano Science Ltd. is the sale and distribution of the SureNano™ surfactant, which is a ready-to-mix food grade compound that provides the base for high performance nanoemulsions to create incredibly homogeneous and stable products while maximizing bioavailability, clarity, and taste. The Company has an exclusive license to distribute the SureNano^TM surfactant within Canada; Oklahoma, USA; and Colorado, USA.

ON BEHALF OF SURENANO SCIENCE LTD.

"Charles MaLette"
CEO, President, Director & Secretary
T: 604-428-5171
E: info@surenano.com

Forward-Looking Information:

This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of SureNano. Forward-looking information is based on certain key expectations and assumptions made by the management of SureNano. In some cases, you can identify forward-looking statements by the use of words such as "will," "may," "would," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "could" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Although SureNano believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because SureNano can give no assurance that they will prove to be correct.

The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/263465

FAQ

What is the price per share for SureNano's (SURNF) private placement and debt settlement?

Both the private placement and debt settlement shares are being issued at $0.10 per share.

How much funding is SureNano (SURNF) raising through its private placement?

SureNano is raising up to $215,000 through a private placement to arms-length investors.

What percentage of SureNano (SURNF) will Charles Malette own after the debt settlement?

After the debt settlement, Charles Malette will own 8,521,600 shares, representing 34.8% of the company's common shares.

What was the shareholder participation rate at SureNano's (SURNF) 2025 AGSM?

10 shareholders representing 70.29% of issued and outstanding shares participated in the AGSM, voting on directors, auditors, and the incentive plan.

How will SureNano (SURNF) use the proceeds from the private placement?

The proceeds will be used for operating expenses, including legal and audit fees, and general working capital.